Propel Bio Management »

Avidity Biosciences Ord shares owned by Propel Bio Management

Quarter-by-quarter ownership of Avidity Biosciences Ord (RNA) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Avidity Biosciences Ord

Tip: Access up to 7 years of quarterly data

All positions including Avidity Biosciences Ord held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avidity Biosciences Ord by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $7.3M 179k 40.85
2024-03-31 $4.6M 179k 25.52
2023-12-31 $1.6M 179k 9.05

More positions owned by Propel Bio Management

Applied Therapeutics Comm (APLT)
Plains Gp Holdings Lp-cl Comm (PAGP)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Achieve Life Sciences Comm (ACHV)
Phathom Pharmaceuticals I Comm (PHAT)
Akero Therapeutics Comm (AKRO)
Avidity Biosciences Comm (RNA)
Ardelyx Comm (ARDX)
Abeona Therapeutics Comm (ABEO)
Fulcrum Therapeutics Comm (FULC)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Verrica Pharmaceuticals I Comm (VRCA)
Kura Oncology Comm (KURA)

View all positions for Propel Bio Management

Top funds holding Avidity Biosciences Ord

T. Rowe Price Associates
BlackRock
BlackRock
RA Capital Management
Vanguard Group
Henderson Group
State Street Corporation
Geode Capital Management
Casdin Capital
Boxer Capital
Siren
Bank of America Corporation
Artisan Partners Limited Partnership
Morgan Stanley
Nuveen Asset Management

View all funds holding Avidity Biosciences Ord